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Abstract
B7-H3 is a cell surface molecule in the immunoglobulin superfamily that is frequently upre-
gulated in response to autoantigens and pathogens during host T cell immune responses.
However, B7-H3's role in the differential regulation of T cell subsets remains largely un-
known. Therefore, we constructed a new B7-H3 deficient mouse strain (B7-H3 KO) and
evaluated the functions of B7-H3 in the regulation of Th1, Th2, and Th17 subsets in experi-
mental autoimmune encephalomyelitis (EAE), experimental asthma, and collagen-induced
arthritis (CIA); these mouse models were used to predict human immune responses in mul-
tiple sclerosis, asthma, and rheumatoid arthritis, respectively. Here, we demonstrate that
B7-H3 KOmice have significantly less inflammation, decreased pathogenesis, and limited
disease progression in both EAE and CIA mouse models when compared with littermates;
these results were accompanied by a decrease in IFN-γ and IL-17 production. In sharp con-
trast, B7-H3 KOmice developed severe ovalbumin (OVA)-induced asthma with characteris-
tic infiltrations of eosinophils in the lung, increased IL-5 and IL-13 in lavage fluid, and
elevated IgE anti-OVA antibodies in the blood. Our results suggest B7-H3 has a costimula-
tory function on Th1/Th17 but a coinhibitory function on Th2 responses. Our studies reveal
that B7-H3 could affect different T cell subsets which have important implications for regu-
lating pathogenesis and disease progression in human autoimmune disease.
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Introduction
Upon T cell receptor-mediated recognition of MHC antigenic peptides, T cell responses to an-
tigens, including autoreactive antigens, are orchestrated by a group of cell surface signaling
molecules. These molecules could be loosely categorized into two distinct types, costimulatory
or coinhibitory molecules, based on their functions in regulating T cell responses. Therefore,
integrating the functional outcome of costimulatory and coinhibitory interactions determines
the fate of a T cell response, which leads to response, unresponsiveness, and death [1]. Various
cell surface signaling molecules have been identified and characterized, including those in the
immunoglobulin (Ig) superfamily and the tumor necrosis factor (TNF) receptor and ligand
superfamily. The roles of these receptors and ligands in the positive and negative control of T
cell immunity and human disease, including autoimmune diseases, have been firmly estab-
lished [2].
In 2001, our laboratory initially identified B7-H3 (CD276) as a costimulatory molecule
that promotes an in vitro T cell response [3]. B7-H3 mRNA has been found in human liver,
lung, bladder, testis, prostate, breast, and placenta, suggesting that B7-H3 may participate in
organ-specific inflammation and autoimmune diseases. The counter-receptor for the costi-
mulatory effect of B7-H3 was reported to be myeloid cell-like transcript 2 factor [4] whereas
other study did not support this finding [5]. Similar to other B7 family homologues, B7-H3
has a single IgV- and IgC-like domain (2Ig form) with a transmembrane and intracellular tail
in humans, mice, and other species. In humans, a duplicate of the classic B7-H3 (4Ig form)
was also identified, but the physiological differences between the 2Ig and 4Ig form have yet to
be elucidated [6–7]. The role of endogenous B7-H3 in the pathogenesis and progression of
autoimmune disease has been evaluated by various laboratories using both monoclonal anti-
bodies (mAb) and B7-H3 deficient mice (KO), but the results are somewhat contradictory
with both costimulatory and coinhibitory effects being described in various model systems
[8–9]. One interpretation for these contradicting results is that B7-H3 plays a differential role
in the regulation of distinct T cell subsets. Therefore, the effect of B7-H3 would be deter-
mined by the dominance or bias of T cell subsets in each system or disease status. It is well
known that CD4+ T cells consist of multiple functional subsets upon encountering antigens
and these subsets regulate T cell responses against different antigens in different and complex
environments. Th1 cells, for example, secrete IFN-γ, IL-2, and GM-CSF; they actively regu-
late T cell proliferation, functional maturation of CD8+ T cells, and activation of several in-
nate immune cell components, including myeloid dendritic cells, macrophages, and
granulocytes. Th1 is pathogenic in multiple human autoimmune diseases and in experimen-
tal models for EAE and CIA. Th2 cells distinguish themselves from other T cell subsets by se-
creting IL-4, IL-5, and IL-13; they actively promote IgE antibody production and regulate the
immune response to allergens, including those involved in asthma and parasitic infections.
Under the influence of IL-6, IL-21, and TGF-β, Th17 cells produces IL-17, and Th17 subsets
regulate several autoimmune diseases, including EAE and CIA. The differentiation of Th
cells appears to be controlled at the transcriptional level: T-bet is critical for generating Th1
cells; GATA largely regulates Th2; RORγt is a master transcription regulator for Th17 [10–
12]. To delineate the role of B7-H3 in the differential regulation of T cell subsets, we con-
structed a B7-H3-deficient mouse strain and studied the differential roles of B7-H3 in these T
cell subsets and in multiple mouse models where pathogenic T cells are biased toward specific
T cell subsets.
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Methods
Ethics statement
B7-H3 KOmice were generated in Mayo Clinic and gene targeting mice protocols were ap-
proved by the Mayo Clinic Institutional Animal Care and Use Committee. All of the experi-
mental animals used in this study were housed in specific pathogen-free environment and
performed under the protocol approved by animal facilities of Johns Hopkins University, Yale
University and Sun Yat-Sen University. When mice are paralyzed in EAE induction procedure,
they were provided with gel pack and/or moistened food in the cage and mice were monitored
daily by both researchers and animal care staff. Animals were euthanized if they were mori-
bund or the experiment was completed. In all cases, mice were humanely sacrificed by using
carbon dioxide.
Generation of B7-H3 KOMice
Amurine B7-H3 genomic DNA clone was identified by screening a 129/SvJ bacterial artificial
chromosome (BAC) library (IncyteGenomics, St. Louis). A 4.6 kb B7-H3 upstream DNA ho-
mologous fragment and a 6.5 kb downstream DNA homologous fragment were PCR amplified
from a positive BAC clone. The fragments were cloned into a pKO targeting vector that con-
tains a neo resistant gene and a TK gene (Stratagene). The targeting vector with the B7-H3 IgV
and IgC domains replaced was transfected into 129/Svj embryonic stem (ES) cells (The 129/Svj
ES cell line was purchased from ATCC, SCRC-1020). Correctly targeted ES cells were con-
firmed by Southern blot analysis and then injected into C57BL/6 mouse blastocytes followed by
implantation into foster mothers to generate chimeric mice. B7-H3 mutant mice were identified
by PCR analysis of tail genomic DNA. The sequences of the PCR primers are: B7-H3 forward,
5’CGGCTCAGTCACCATCACAGGTAA; B7-H3 reverse, 5’GAGCCGCAATGAGCCTAAGGTCTA;
Neo forward, 5’AGACTAGTGAGACGTGCTACTTCCA. The mice were backcrossed to a C57BL/
6 or a DBA/1J background for ten generations. The same generations of homozygous or wild
type mice were used for experimental analysis.
Induction of EAE
The wild type (wt) and B7-H3 KOmice (C57BL/6, male, 8–10 week old) were immunized sub-
cutaneously (s.c.) at both flanks with 200 μl of emulsion comprising 200 μg MOG 33–35 pep-
tide, 400 μgMycobacterium Tuberculosis (Difco) and complete Freund’s adjuvant (CFA)
(Difco) on day 0; and injected intraperitoneally (i.p) with 400 μg pertussis toxin (Sigma-Al-
drich) on the same day and day 2. Mice were scored every other day for signs of EAE on 0–5
scales as follows: 0, no abnormality; 1, complete loss of tail tonicity; 2, flaccid tail and abnormal
gaits; 3, hind leg paralysis; 4, hind and foreleg paralysis; 5, death.
Induction and analysis of asthma
Wt and B7-H3 KOmice (C57BL/6, male, 8–10 weeks old) were sensitized via i.p. injection of
20 μg OVA protein (Sigma-Aldrich) adsorbed to 4 mg aluminum hydroxide Gel (Sigma-Al-
drich) on days 0 and 5. Then, mice were challenged with aerosolized 1% OVA in PBS using a
nebulizer (Proneb Ultra II) for 60 minutes on days 12–14. Mice were sacrificed the next day
(some mice were sacrificed on day 12 for in vitro proliferation and Th cells differentiation ex-
periments). Blood was collected and serum was separated for OVA-specific IgE determination.
The trachea was cannulated and the lungs were lavaged 3 times with a total of 1.5 ml of PBS.
The bronchoalveolar lavage fluids (BALF) were centrifuged. The supernatants were collected
to determine cytokine IL-5 and IL-13 levels and the cell pellets were re-suspended in 1 ml of
B7-H3 in Autoimmune Diseases
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PBS. Half a milliliter of suspended cells were counted using a Cell Viability Analyzer (Beckman
Coulter) to determine the total cell counts in the BALF; the rest was spun onto microscope
slides by CytoFuge and stained with Hema3 (Fisher Scientific). BALF differential cell counts
were identified by counting 400 cells per slides using a high-magnification microscope. The rel-
ative numbers of each cell type were calculated by multiplying the total cell counts by the per-
centage of each cell type in the BALF cells. For histopathology analysis of lung inflammation,
peribronchial and perivascular inflammation was evaluated on a scale of 0–4, for no inflamma-
tion (0), few inflammatory cells present (1), a few loci of inflammation (2), multiple loci of in-
flammation (3), inflammatory cells throughout the lung (4). The scores were presented as
mean ± SEM. For mucus-secreting cells in the airways, mucous scores of 0–3 were evaluated
for: no positive cells present (0), a few positive cells (1), many positive cells (2), and extensive
staining of mucus-secreting cells (3)[13].
Induction of collagen-induced arthritis (CIA)
Chicken Collagen II (CII, Sigma-Aldrich) was dissolved in 10 mM acetic acid at 4 mg/ml and
emulsified with an equal volume of CFA (Difco). Wt and B7-H3 KOmice (DBA/1J, male, 8–10
week old) were immunized s.c. at both flanks with 100 μl of emulsion and a boosted with the
same concentration of CII (emulsified in IFA for this immunization) 16 or 18 days after the
primary immunization. Animals were evaluated by visual inspection for arthritis incidence; se-
verity was scored individually on a 0–4 scale [14]. Scores from all four paws were added to give
the total for each animal.
In vitro T cell proliferation response
The brachial and axillary draining-lymph nodes (DLN) cells were isolated from wt or B7-H3
KOmice 10 days post MOG/CFA immunization. Splenocytes were removed from the OVA-
immunized wt or B7-H3 KOmice 12 days after their first immunization and from wt or B7-H3
KO CIA mice 20 days after the primary immunization, respectively. The DLN cells or spleno-
cytes were cultured in 96-well culture plates with various doses of MOG peptide, OVA, or CII
proteins (heated for 30 minutes at 60°C). The proliferative activity of the T cells was assessed in
triplicates by 3H-thymidine incorporation during the last 6 hours of the 3 days culture.
Cytokine measurement
Cytokines in BALF and cultured supernatants were measured using OptEIA kits (BD Pharmin-
gen) for IL-2, IL-12, IL-5, IFNγ and ELISpot Kit (R&D Systems) for IL-13. In the CIA experi-
ments, IL-2, IL-4, IL-6, IL-10, TNF, IFN-γ, and IL-17A from the culture supernatants were
assessed by CBA mouse Th1/Th2/Th17 Cytokine kit (BD Biosciences) and the data were ana-
lyzed using an FCAP Array V2.0.
ELISA Measurement of OVA-specific IgE and anti-CII IgG
For OVA-specific IgE, ELISA plates were coated with 100 μg/ml of OVA at 4°C overnight. The
plate was washed and blocked with 1% BSA for 2 h at room temperature. 1:50 diluted serum
samples were incubated at room temperature for 2h, followed by treatment with HRP-conju-
gated anti-mouse IgE (BD Pharmingen). After washing, peroxidase substrate was added and
the absorbance was read at 450 nm with an automated ELISA reader. For anti-CII IgG, serum
was collected from CIA mice 20 days after their primary immunization and the levels of anti-
type II collagen Ab (IgG) were assayed using a mouse anti-type II collagen IgG assay kit (Chon-
drex Inc) according to manufacturer's instructions.
B7-H3 in Autoimmune Diseases
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In vitro differentiation of Th1 and Th2 cells and intracellular staining
DLN cells (EAE model) or splenocytes (asthma model) from wt or B7-H3 KOmice were cul-
tured with MOG peptide (40 μg/ml) or OVA (50 μg/ml) under Th1 (10 ng/ml IL-12, 10 μg/ml
anti-IL-4) or Th2 (10 ng/ml IL-4, 10 μg/ml anti-IFNγ and 10 μg/ml anti-IL-12) polarizing con-
ditions for 5 days. 1 μg/ml of anti-CD3 and 1 μl/ml of GolgiPlug was added during the last 6 h.
The cells were stained for surface CD4, then fixed and permeabilized using the Cytofix/Cyto-
perm kit (BD Biosciences) followed by intracellular staining for IFN-γ and IL-4.
RT-PCR and Real-time quantitative RT-PCR (qRT-PCR) assay
Total RNA was extracted using the RNeasy kit (Qiagen). First-strand cDNAs was synthesized
and amplified by RT-PCR using a primer set for mouse B7-H3: 5’ GACACGGATGCCACCCT
ACGCTG (forward) and 5’CTGTGATGGTGACTGAGCCGTGAG (reverse). β-actin mRNA levels
were determined as a control for each sample. For real-time qRT-PCR, total RNA was ex-
tracted using RNeasy (Qiagen) and was reverse transcribed to cDNA using Taqman reverse
transcription reagents (Applied Biosystems) according to the manufacturer’s instructions.
Primer and probe sets were obtained from Applied Biosystems. Real-time qPCR was per-
formed using the Taqman Universal PCR Master Mix and an Applied Biosystems 7500 Fast
Real-Time PCR system. Relative gene expression levels were normalized to the 18S rRNA en-
dogenous control levels.
Histopathology and Immunohistochemistry
Lungs from allergic mice were fixed with Streck Tissue Fixative (Streck). The lung sections
were stained with hematoxylin and eosin (H&E) or Periodic Acid-Schiff (PAS) (Sigma-Al-
drich) for histological evaluation. Intact spinal cords were flushed out by hydrostatic pressure
from mice 20 days after MOG/CFA immunization and fixed in 10% formalin. The sections
were stained with H&E to assess inflammatory lesions. The hind paws from normal or CIA
mice were collected 40 days after their primary immunization. The skins were removed from
their paws and the bones were decalcified using Formical 2000 (Decal Chemical Corporation)
for 24 hrs followed by fixation with SafeFix II (Fisher Scientific). After deparaffinization and
rehydration, the tissue sections were stained with H&E for histological analysis. For immuno-
histochemistry, endogenous peroxidases, nonspecific binding sites and endogenous avidin/bi-
otin were blocked using 0.3% H2O2, Block AEC (AbD Serotec), and Avidin Blocking Buffer
(Vector Laboratories), respectively. Then, sections were incubated with an anti-mouse biotin-
conjugated B7-H3 mAb (5 μg/ml) at 4°C overnight. Subsequently, the Catalyzed Signal Ampli-
fication System (DAKO, K1500) was used for staining. The slides were counterstained with he-
matoxylin. Monoclonal antibody to murine B7-H3 (clone mB7-H3.7H) was generated by
immunizing an Armenia hamster with mouse B7-H3Ig recombinant fusion protein, as de-
scribed previously [3].
Statistical analysis
All statistics were performed using a two-tailed Student’s t test. All bars are shown as
mean ± standard error of the mean (SEM).
Results
Generating B7-H3 knockout (KO) mice
The B7-H3 KOmice were generated using homologous recombination in embryonic stem (ES)
cells. The targeting vector was constructed to replace exon 2 and exon 3 of the B7-H3 gene
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with a TK gene and a neomycin resistance gene. Homologous recombination by this targeting
vector in ES cells deleted a 2 kb region that encodes for the IgV and IgC domains of B7-H3 (Fig
1A). Using Southern blot analysis, we identified one correctly targeted ES clone from the 480
G418-resistant colonies (Fig 1B), and then injected this clone into 129 mice blastocytes to gen-
erate chimeric mice. The strains of C57BL/6 genetic background mice were established by
backcrossing chimeric mice with C57BL/6 mice for>10 generations. Wild type, heterozygous,
or homozygous B7-H3 mutant mice were identified using mouse tail genomic DNA and PCR
analysis (Fig 1C). The absence of B7-H3 mRNA in KO mice was also confirmed by RT-PCR
using cDNA generated from spleen cells (Fig 1D). The mutant mice were monitored up to one
year and were viable, fertile, normal in size, and did not display any visible physical abnormali-
ties. In addition, the mutant mice displayed normal numbers and ratios of T, B, NK, and DC
cells in the thymus, spleen, and lymph nodes (data not shown).
B7-H3 KOmice are resistant to EAE
To investigate the in vivo function of B7-H3 in autoimmune disease, we first examined the role
of B7-H3 on the development of EAE. As shown in Fig 2, the onset of disease in B7-H3 KO
mice was similar to that in wt mice; however, B7-H3 KOmice exhibited attenuated symptoms
during the course of EAE development, specifically 16 days post-immunization. The mean
maximal clinical score in B7-H3 KOmice was markedly less than that in wt mice. In most
B7-H3 KOmice, the disease was not fatal and the mice demonstrated a partial recovery from
Fig 1. Generation and characterization of B7-H3 KOmice. (A) Mapping of the B7-H3 genomic locus, targeting vector, and the replaced allele. (B)
Southern blot analysis of SpeI-digested DNA from targeted embryonic stem (ES) cell clones. The wild-type allele generated a 9.6-kb fragment, and the
targeted allele yielded an 8.0-kb fragment. (C) PCR identification of genomic DNA isolated from tails of wild type (+/+), heterozygous (+/−) or homozygous
(−/−) B7-H3 mutant mice. The wild type allele generated an 894-bp fragment and the targeted allele generated a 632-bp fragment. (D) Examination of B7-H3
mRNA by RT-PCR. The cDNA was generated from the spleens of wild type (+/+), heterozygous (+/−) or homozygous (−/−) B7-H3 mutant mice using primers
specific for B7-H3 or β-actin (control).
doi:10.1371/journal.pone.0130126.g001
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their EAE symptoms (Fig 2). Consistent with these observations, histopathological examina-
tions showed a massive infiltration of mononuclear cells in the proximal spinal cord region of
wt mice, while there were fewer inflammatory cells in the same region of B7-H3 KOmice (S1
Fig). Though disease severity was significantly reduced in B7-H3 KOmice, their disease inci-
dence is also 100%, the same as wt group. These results indicate that our newly developed
B7-H3 KOmice are more resistant to EAE than wt mice.
Myelin-specific T cell response is reduced in B7-H3 KOmice
Myelin-specific T cells play an important role in EAE animal models. To confirm our in vivo
findings, we investigated whether there was a difference between wt and B7-H3 KO mouse T
cell-specific responses to MOG 33–35 peptide. The brachial and axillary draining-lymph
nodes (DLN) were removed from wt or B7-H3 KO mice 10 days after MOG/CFA immuniza-
tion. Although the DLNs from both the wt and B7-H3 KO mice exhibited swelling, the latter
was visibly smaller. The total cell number obtained from DLN in the B7-H3 KO mice was
half the number or less of wt mice (Fig 3A). The DLN cells were then isolated and re-stimu-
lated with various doses of MOG peptide in vitro. DLN cells isolated from wt mice induced a
strong proliferative response upon MOG peptide stimulation and in a dose-dependent man-
ner; whereas DLN cells isolated from B7-H3 KO mice responded poorly (Fig 3B). Meanwhile,
we determined the concentrations of T-helper cell type 1 (Th1) cytokines and IL-17 in the
culture supernatants. The DLN cells from B7-H3 KO mice produced fewer IFN-γ, IL-12, and
IL-17 than the DLNs isolated from wt mice (Fig 3C). We further assessed the Th1/Th2 differ-
entiation of DLN cells from primed wt or B7-H3 KO mice in vitro. In the presence of MOG
peptides, the DLN cells from the wt mice produced a significant number of IFN-γ producing
Fig 2. B7-H3 KOmice are resistant to EAE. EAE incidence and severity in wild type and B7-H3 KOmice. Data are presented as an average clinical score
from four independent experiments (5–10 mice each group). There were significant differences between two groups starting on day 16. Data are shown as
mean ± SEM,*p<0.05, **p<0.01, ***p<0.001, versus control.
doi:10.1371/journal.pone.0130126.g002
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cells under Th1 polarizing conditions, but very few numbers of IL-4 producing cells under
Th2 polarizing conditions; this is consistent with EAE's Th1-type response. However, DLN
cells from B7-H3 KO mice generated a decreased proportion of IFN-γ producing cells under
Th1 polarizing conditions (Fig 3D). T-bet has been identified as a key transcription factor in
Th1 cell development, so we further compared the levels of T-bet mRNA in the DLN cells
from wt and B7-H3 KO mice 10 days after MOG/CFA immunization using real time quanti-
tative RT-PCR. T-bet mRNA levels were reduced in DLN cells from the B7-H3 KO mice
compared with that of wt mice. In contrast, there was not a difference between the levels of
GATA-3 mRNA in wt and B7-H3 KO mice (Fig 3E). Therefore, the reduced myelin-specific
T cell responses to MOG peptide which may be caused by the decreased Th1 cell differentia-
tion, proliferation and/or survival.
Fig 3. Decreased MOG-specific T cell responses in B7-H3 KOmice. The brachial and axillary draining-lymph nodes (DLN) were removed from wild type
and B7-H3 KOmice 10 days after MOG/CFA immunization. (A) Comparing DLN size and number. Representative image of wt and B7-H3 KOmice DLNs
(top), which taken from one mouse per group. DLNs number counting is from five mice per group (bottom). Data are representative of three independent
experiments. (B) Proliferative response of DLN cells to MOG peptide, as determined by incorporation of 3H-TdR. DLNs were collected from five mice per
group. Data are representative of four independent experiments with similar results. (C) Cytokine IL-2, IL-12, IL-17, and IFN-γ concentrations in cultured
supernatants of DLN cells were measured by ELISA 2 days after restimulation with MOG peptide (40 μg/ml). Data are representative of three independent
experiments with similar results. (D) DLN cells (mixed 5 individual cells per group) were cultured with MOG peptide (40 μg/ml) for 5 days under Th1 or Th2
polarizing conditions. Then, Th1 and Th2 cell subpopulations were analyzed by intracellular cytokine staining. Data are representative of 3 independent
experiments with similar results. (E) Real-time PCR analysis of T-bet and GATA3 were performed on cDNA from wt and B7-H3 KOmice DLN cells, 5
individual cells per group in triplicates. Data are representative of 2 independent experiments. Data are shown as mean ± SEM, *p<0.05, **p<0.01,
***p<0.001, versus control.
doi:10.1371/journal.pone.0130126.g003
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Enhanced airway allergic response in B7-H3 KOmice
Next, we examined whether a reduction in B7-H3 could cause an imbalance in the Th1 and
Th2 response in Th2 lymphocytes' predominant immune response. Wt and B7-H3 KOmice
were immunized via i.p. injection of OVA-aluminum, and then challenged with aerosolized
OVA protein. The bronchoalveolar lavage fluids (BALF) were harvested and the total and dif-
ferential BALF cell counts were determined. The total BALF cell counts in OVA-immunized
and challenged B7-H3 KOmice were significantly higher than in wt mice; this increase was
mainly observed in eosinophils (Fig 4A and 4B). Histological examination of lung tissue re-
vealed numerous inflammatory cells concentrated around the bronchovascular bundles in
B7-H3 KOmice, and many PAS-positive cells were observed in small airways. Quantitation of
these focal inflammation and mucus production demonstrate a significantly increased inflam-
mation and mucus production scores. Meanwhile, there was limited infiltration and only a few
PAS-positive cells in the same regions in wt mice (Fig 4C). This indicates that airway inflam-
mation is more serious in the lung tissue of B7-H3 KOmice. Analysis of the Th2 cytokines, IL-
5 and IL-13, in BALF showed that B7-H3 KOmice exhibited increased levels of IL-5 and IL-13
in BALF compared with wt mice (Fig 4D). We also assayed OVA-specific IgE levels in serum
from wt and B7-H3 KOmice that were immunized and challenged with OVA and found that
OVA-specific IgE was increased in B7-H3 KOmice compared with wt mice (Fig 4E). These re-
sults indicate that B7-H3 KOmice enhance Th2-mediated allergic responses in the airway.
Fig 4. Enhanced airway allergic responses in B7-H3 KOmice. (A) Total and eosinophil cell counts in BALF from OVA protein-immunized and challenged
wild type or B7-H3 KOmice. Data were from 5 individual mice per group each experiment and data are representative of four independent experiments. Eos,
eosinophils; Macs, macrophage; Lymphs, lymphocytes; PMNs, polymorphonuclear neutrophils. (B) Characterization of inflammatory cells in BALF. The cells
were spun to slides, and then stained with HEMA3 (Original magnification: ×60). (C) Lung paraffin sections of naïve, allergic wild type, and B7-H3 KOmice
were stained with H & E and PAS (Original magnification: ×20). Peribronchial and perivas cular inflammation and mucus-secreting cells in the airways were
scored (right plots). (D) Th2 cytokine levels in BALF of wild type or B7-H3 KOmice assessed by ELISA. (E) Levels of serum OVA-specific IgE were
determined by ELISA in wild type and B7-H3 KOmice after OVA protein challenge. Data are shown as mean ± SEM, *p<0.05, **p<0.01, ***p<0.001,
versus control.
doi:10.1371/journal.pone.0130126.g004
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Elevated Th2 response in B7-H3 KO
To confirm further that the increased airway inflammation in the lungs of B7-H3 KOmice is
associated with an enhanced Th2 response, the splenocytes from OVA-immunized wt or
B7-H3 KOmice were re-challenged with OVA protein in vitro. Splenocytes from B7-H3 KO
mice exhibited a marked proliferation compared to wt mice (Fig 5A). When stimulated with
OVA protein under Th2 polarizing conditions, splenocytes from B7-H3 KOmice induced a
larger proportion of IL-4 producing cells than that from wt mice (Fig 5B). Therefore, the en-
hanced Th2 cell polarization in B7-H3 KOmice involved a more severe allergic response in the
airways. We also assessed the production of IL-17 in splenocytes from OVA protein challenged
wild type or B7-H3 KOmice following restimulation in vitro with PMA + ionomycin for 5 hrs.
Intracellular cytokine staining revealed that there are fewer IL-17+ cells in CD4+ splenocytes
for both wt and B7-H3 KOmice (Fig 5C). Although the number of IL-17 producing cells in
B7-H3 KOmice is a little higher than wt mice, it is uncertain whether IL-17 is involved in the
mechanism by which B7-H3 KOmice develop more severe airway inflammation. To further
understand the mechanism whereby Th2 response is enhanced in B7-H3 KOmice, we ana-
lyzed the expression of GATA3, a principal transcriptional activator of Th2 cell differentiation,
in the splenocytes of wt and B7-H3 KOmice with induced asthma. Real time RT-PCR analysis
indicated that GATA3 mRNA levels were significantly increased in B7-H3 KOmice compared
with that in wt mice (Fig 5D). These results suggest that enhanced GATA3 mRNA expression
in CD4+ cells from B7-H3 KOmice may be associated with the predominant Th2 cell re-
sponses during the development of allergic respiratory inflammation.
Decreased CIA severity in B7-H3 KOmice
CIA is the most widely used mouse model for rheumatoid arthritis, a common autoimmune
disease. The CIA model is thought to be an auto-reactive T and B cell-dependent arthritis, and
recent studies have suggested that Th17 cells play a central role in the pathogenesis of CIA.
Therefore, we tested the effect of B7-H3 in the development of CIA. B7-H3 KOmice exhibited
a later onset, an attenuated severity of arthritis based on the assigned arthritis score (Fig 6A),
and a decreased severity in joint swelling (Fig 6B) compared with wt mice. Clinical observation
was further verified by histological examination. H&E staining of arthritic paw joints from wt
mice revealed severe synovial hyperplasia, infiltration of inflammatory cells, and destructive
cartilage and bone. In contrast, the levels of inflammation, infiltration, and cartilage erosion
were markedly alleviated in B7-H3 KOmice (Fig 6C). In addition, CII-specific IgG levels in
sera from B7-H3 KOmice were significantly lower than those from wild type mice, as deter-
mined by ELISA 20 days after primary immunization (Fig 6D). Our results indicate that B7-H3
KOmice have significantly decreased symptoms of CIA.
B7-H3 expression is correlated with arthritic inflammation
Next, we investigated whether arthritic inflammation was associated with local B7-H3 ex-
pression. Mouse paw joint sections in normal mice were immunohistochemically stained for
B7-H3; the osteoblasts surrounding the calcaneus were positive for B7-H3, as well the sec-
tions of the distal tibia. Staining sections of wt mice with CIA showed a heightened expres-
sion of B7-H3 that was accompanied by an increase in osteoblast number, compared with
normal tissue. This effect was completely lost in CIA-B7-H3 KO mice, which demonstrated a
complete lack of B7-H3 expression in osteoblasts (Fig 6E). Therefore, B7-H3 is induced dur-
ing arthritic inflammation of paw joints, which is positively correlated with the progression
of arthritic diseases.
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Fig 5. Predominant Th2 response in B7-H3 KOmice. Spleens were removed from OVA protein-immunized wild type and B7-H3 KOmice on day 12. (A)
Splenocytes were restimulated with varying concentrations OVA protein. Cell proliferation was determined by 3H-TdR incorporation. 5 mice per group and
data are representative of 3 independent experiments with similar results. (B) Splenocytes (mixed 5 individual cells per group) were cultured with OVA
protein (50 μg/ml) for 5 days under Th-1 or Th-2 polarizing conditions. Th1 and Th2 cell subpopulations were analyzed by intracellular cytokine staining. Data
are representative of three independent experiments with similar results. (C) Splenocytes from wt or B7-H3 KOmice were restimulated with PMA (5ng/ml)
+ ionomycin (250 ng/ml) and GolgiPlug (1 μl/ml) in vitro for 5 hrs. IL-17 producing cells were analyzed by flow cytometry. 5 mice per group and data are
representative of 2 independent experiments. (D) Real-time PCR analysis of T-bet and GATA3 were performed on the cDNA from 5 individual splenocytes
per group in triplicates. Data are representative of 2 independent experiments. Data are shown as mean ± SEM, *p<0.05, **p<0.01, ***p<0.001,
versus control.
doi:10.1371/journal.pone.0130126.g005
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CII specific T cell proliferative response and cytokine production are reduced in B7-H3
KOmice. To investigate CII antigen-specific T cell response and cytokine production in CIA
wild type and B7-H3 KOmice, splenocytes were removed from arthritic mice 20 days after the
primary immunization and were restimulated with different doses of CII protein in vitro. Sple-
nocyte response to CII was significantly attenuated in the B7-H3 KOmice compare with that
in wt mice (Fig 6F). Accordingly, cytokine IFN-γ, IL-2, IL-6, TNF, and IL-17 production was
significantly reduced in cultured splenocytes from B7-H3 KOmice (Fig 6G) while IL-4 and IL-
10 were expressed at minimal levels (<10pg/ml) (data not shown). These results suggest that
Th1, Th17, and B cell responses were suppressed in the CIA-B7-H3 KOmice.
Discussion
Here, we construct a new B7-H3 deficient mouse strain and use this new strain to test how
B7-H3 regulates the immune response to antigen in mouse models of autoimmune disease and
Fig 6. B7-H3 KOmice are resistant to CIA. (A) The arthritis score in CIA mice. 5–10 mice per group per experiment and data shown are representative of 3
independent experiments with similar results. (B) Representative images of hind paws from wild type (left) and B7-H3 KO (right) CIA mice on 40 days after
primary immunization. (C) Representative hematoxylin and eosin—stained sections of toe and talus joints (original magnification ×4 and ×10, respectively)
from wild type and B7-H3 KO CIA mice. (D) Serum anti-type II collagen Ab (IgG) levels (100 units is approximately 0.1 mg IgG antibody/ml). Data shown are
representative of 3 independent experiments. (E) Staining for B7-H3 in normal and arthritic joints. Hind toe joints from normal, CIA-wild type, and B7-H3 KO
mice (Original magnification ×10). (F) Splenocytes from wild type and B7-H3 KO CIA mice were restimulated with chicken CII protein in various
concentrations. 5 mice per group each experiment. Cell proliferation was determined by 3H-TdR incorporation. Data shown are representative of 3
independent experiments. (G) Th1/Th2/Th17 Cytokine concentrations of cultured supernatants from chicken CII protein (20 μg/ml)-restimulated splenocytes
(mixed 5 individual cells per group) after 1 and 2 days were assessed using mouse Th1/Th2/Th17 Cytokine kits (CBA); data were analyzed using FCAP
Array V2.0. Data shown are representative of two independent experiments. Data are shown as mean ± SEM, *p<0.05, **p<0.01, ***p<0.001,
versus control.
doi:10.1371/journal.pone.0130126.g006
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asthma. We reveal an unexpected role for B7-H3: B7-H3 differentially regulates Th1/Th17 and
Th2 responses in the models we studied. A lack of B7-H3 ameliorated the effects of EAE and
significantly decreased symptoms of CIA, which were accompanied by a decrease in Th1- and/
or Th17-type cytokine responses to autoantigens. In contrast, we also noted a significantly en-
hanced Th2-type cytokine response and increased airway inflammation in B7-H3 KO mice.
Thus, our findings not only reveal a dichotomy for B7-H3's role in the regulation of T cell sub-
sets, but also provide important clues that will assist in designing new immune modulations
that target this pathway and treat disease.
The effect of B7-H3 on the regulation of T cell responses has been evaluated in in vitro cell
culture systems and various murine models using transfection to overexpress B7-H3 monoclo-
nal antibodies (mAb) against B7-H3 and B7-H3 KOmice. These studies resulted in inconsis-
tent and conflicting results from different laboratories. In vitro studies using human
recombinant B7-H3 showed enhanced T cell growth in the presence of TCR engagement,
which led to the hypothesis that B7-H3 is a costimulatory molecule for T cell growth [3]. Using
transfection to overexpress B7-H3 on cancer cells, researchers enhanced immune responses,
especially in CD8+ T cell compartments; this was demonstrated by several investigators [15–
18]. Therefore, B7-H3 over-expression seemed costimulatory in T cell responses. Various anti-
bodies against murine B7-H3 were generated independently by different laboratories and have
been evaluated in mouse models and in in vitro systems; these results are inconsistent. For ex-
ample, infusion of a B7-H3 mAb accelerated the progression of diseases with an enhanced Th1
T cell response in a MOG peptide-induced EAE model [19]. In addition, a B7-H3 mAb en-
hanced the Th2-mediated T cell response during induction of experimental allergic conjuncti-
vitis [20]. While these data support a role for endogenously expressed B7-H3 to suppress CD4
+ T cell responses, several studies employing different antibodies suggest a possible role for
B7-H3 in the promotion of Th2 and Th1/CD8 T cell responses. Administration of a B7-H3
mAb reduced airway hypersensitivity by suppressing Th2 cytokine production and decreasing
the number of eosinophils in the airway [21]. Furthermore, an independently generated B7-H3
mAb suppressed a CD8+ and CD4+ T cell-mediated contact hypersensitivity [4]. Although
these mAbs all claimed to be “blocking or antagonist” antibodies, it is unknown whether these
mAbs are truly antagonistic or could behave as both an antagonist and agonist. Because
B7-H3's counter-receptor has yet to be characterized, a simple and straightforward blocking
assay is not yet available. In addition to serving as ligands, several B7 family molecules includ-
ing B7-2 and B7-H1 could also serve as receptors [2]. Therefore, it remains possible that B7-H3
could serve as a receptor and some of these B7-H3 mAbs could signal via B7-H3, as suggested
in a recent study [22].
Two B7-H3 KOmouse strains were independently generated and characterized in addition
to our current study [23–24]. Wang and colleagues showed that survival of allogeneic islets and
cardiac grafts were significantly prolonged, accompanied by a decreased T cell response in
B7-H3 KOmice. While this finding supports a costimulatory function for B7-H3 in T cell re-
sponses, the effect of B7-H3 on T cell subsets and their contribution to autoimmune disease
were not evaluated [23]. In an independently generated B7-H3 KO strain, Suh and colleagues
showed a small but significant increase in Th1-mediated lung inflammation, whereas Th2 re-
sponses remained unchanged in a cytokine/aerosolized ovalbumin-induced lung inflammation
model [24]. Similarly, this strain showed a small increase in clinical score, autoantibody pro-
duction, and a slightly earlier onset in MOG-induced EAE models. In this model, CTL re-
sponses to LCMV were indifferent. Due to the relatively weaker phenotypes across all of the
tests in this mouse strain, a different genetic background (F2 C57BL/6 x 129/Ola or F6 BALB/
c) and a different lung model of inflammation, a direct comparison between this model and
our strain is difficult. In a lung inflammation model, Suh et al used GM-CSF with or without
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IL-12 to prime the lung before using OVA challenge to induce the Th1 or Th2-biased status. In
our lung inflammation/asthma model, the B7-H3 KO strain was challenged with OVA in alum
adjuvant to bias Th2 responses. Therefore, a significantly enhanced Th2 response was observed
in our studies, where indifference was observed in the model produced by Suh and colleagues.
In a MOG-peptide induced EAE model, a small increase in the clinical score and accumulation
of autoantibodies were observed [24]. These results suggest a role for B7-H3 in suppressing
Th1 function since the EAE in this model is mainly mediated by Th1 and Th17. In our study, a
similar method was used to induce EAE but we observed a dramatic decrease in the clinical
score, infiltration of lymphocytes into CNS, T cell response to MOG antigen, Th1 and Th17 cy-
tokine, and T-bet mRNA in B7-H3 KOmice (Fig 3). Thus, our results indicate a positive regu-
latory role of B7-H3 in EAE. One possible reason for the difference between these two models
may be the genetic background: genetic variations in F2 C57BL/6 x 129/Ola mice may be larger
than in our strain of C57BL/6 [24].
It is particularly interesting that B7-H3 KOmice were resistant to CIA induction, showed
fewer clinical symptoms and a decreased pathogenesis, including diminished infiltration of in-
flammatory cells to the joints, decreased T cell and antibody responses to collagen, and fewer
inflammatory cytokines including those secreted by Th1 and Th17. Although B7-H3 mRNA is
widely distributed in various normal tissues, the protein is not typically detectable. In previous
mouse studies, B7-H3 was found expressed on osteoblasts which required a late phase of osteo-
blast differentiation [25]. Using immunohistochemical staining with anti-B7-H3 mAb, we
demonstrated that B7-H3 cell surface proteins could be detected, albeit in low levels, in the paw
joints of normal mice, mainly expressed in osteoblasts on the surface cartilage. Importantly,
the expression of B7-H3 is drastically upregulated in collagen-immunized mice and was corre-
lated with the level of arthritic inflammation and bone destruction. The clinical symptoms of
CIA and joint inflammation and destruction were markedly reduced in B7-H3 KOmice com-
pare to the control mice. In vitro experiments demonstrated that collagen-specific T cell re-
sponses were significantly decreased and IFN-γ, TNF and IL-17 cytokine production was
accordingly reduced in B7-H3 KOmice. Our observations suggest that B7-H3 may be an im-
portant mediator of pathogenesis and progression in inflammatory arthritis.
Taken together, our results support the notion that B7-H3 differentially regulates T cell
subsets by costimulating Th1 and Th17 while suppressing Th2 responses. This finding may
explain, at least in part, the previously contradictory findings in various model systems. The
molecular basis for this differential effect, however, has yet to be characterized. This will
largely rely on the discovery of the B7-H3 counter-receptor and, in this regard, a different
counter-receptor on these T cell subsets may cause the observed effects. Finally, our findings
have important implications for the manipulation of B7-H3 in clinical applications to treat
human disease.
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KOmice on day 20 post-immunization. The paraffin tissue sections were stained with hema-
toxylin and eosin (original magnification: ×5 and ×20).
(TIF)
Acknowledgments
We thank Beth Cadugan for editing the manuscript, Janis Taube for help with histopatholog-
ical image analysis.
B7-H3 in Autoimmune Diseases
PLOS ONE | DOI:10.1371/journal.pone.0130126 June 11, 2015 14 / 16
Author Contributions
Conceived and designed the experiments: LL IM ZZ LC. Performed the experiments: LL GZ
HX SY GZ YZ KT LH ADFMBWR JMAD IM. Analyzed the data: LL GZ SY YZ KT JMAD
IM ZZ LC. Contributed reagents/materials/analysis tools: GZ LH IM ZZ. Wrote the paper: LL
GZ SY YZ KT ZZ LC.
References
1. Zhu Y, Yao S, Chen L. Cell surface signaling molecules in the control of immune responses: a tide
model. Immunity. 2011 Apr 22; 34(4):466–478. doi: 10.1016/j.immuni.2011.04.008 PMID: 21511182
2. Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol.
2013 Apr; 13(4):227–242. doi: 10.1038/nri3405 PMID: 23470321
3. Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, et al. B7-H3: a costimulatory molecule for T cell
activation and IFN-gamma production. Nat Immunol. 2001 Mar; 2(3):269–274. PMID: 11224528
4. Hashiguchi M, Kobori H, Ritprajak P, Kamimura Y, Kozono H, AzumaM. Triggering receptor expressed
on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses.
Proc Natl Acad Sci U S A. 2008 Jul 29; 105(30):10495–10500. doi: 10.1073/pnas.0802423105 PMID:
18650384
5. Leitner J, Klauser C, Pickl WF, Stockl J, Majdic O, Bardet AF, et al. B7-H3 is a potent inhibitor of human
T-cell activation: No evidence for B7-H3 and TREML2 interaction. Eur J Immunol. 2009 Jul; 39
(7):1754–1764. doi: 10.1002/eji.200839028 PMID: 19544488
6. Sun M, Richards S, Prasad DV, Mai XM, Rudensky A, Dong C. Characterization of mouse and human
B7-H3 genes. J Immunol. 2002 Jun 15; 168(12):6294–6297. PMID: 12055244
7. Steinberger P, Majdic O, Derdak SV, Pfistershammer K, Kirchberger S, Klauser C, et al. Molecular
characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. J Immunol.
2004 Feb 15; 172(4):2352–2359. PMID: 14764704
8. Yi KH, Chen L. Fine tuning the immune response through B7-H3 and B7-H4. Immunol Rev. 2009 May;
229(1):145–151. doi: 10.1111/j.1600-065X.2009.00768.x PMID: 19426220
9. Hofmeyer KA, Ray A, Zang X. The contrasting role of B7-H3. Proc Natl Acad Sci U S A. 2008 Jul 29;
105(30):10277–10278. doi: 10.1073/pnas.0805458105 PMID: 18650376
10. Yamane H, Paul WE. Early signaling events that underlie fate decisions of naive CD4(+) T cells toward
distinct T-helper cell subsets. Immunol Rev. 2013 Mar; 252(1):12–23. doi: 10.1111/imr.12032 PMID:
23405892
11. Yamane H, Paul WE. Cytokines of the gamma(c) family control CD4+ T cell differentiation and function.
Nat Immunol. 2012 Nov; 13(11):1037–1044. doi: 10.1038/ni.2431 PMID: 23080204
12. Basu R, Hatton RD, Weaver CT. The Th17 family: flexibility follows function. Immunol Rev. 2013 Mar;
252(1):89–103. doi: 10.1111/imr.12035 PMID: 23405897
13. Sevin CM, NewcombDC, Toki S, HanW, Sherrill TP, Boswell MG, et al. Deficiency of gp91phox inhibits
allergic airway inflammation. Am J Respir Cell Mol Biol. 2013 Sep; 49(3):396–402. doi: 10.1165/rcmb.
2012-0442OC PMID: 23590311
14. Brand DD, Latham KA, Rosloniec EF. Collagen-induced arthritis. Nature protocols. 2007; 2(5):1269–
1275. PMID: 17546023
15. Sun X, Vale M, Leung E, Kanwar JR, Gupta R, Krissansen GW. Mouse B7-H3 induces antitumor immu-
nity. Gene Ther. 2003 Sep; 10(20):1728–1734. PMID: 12939639
16. Lupu CM, Eisenbach C, Lupu AD, Kuefner MA, Hoyler B, Stremmel W, et al. Adenoviral B7-H3 therapy
induces tumor specific immune responses and reduces secondary metastasis in a murine model of
colon cancer. Oncol Rep. 2007 Sep; 18(3):745–748. PMID: 17671729
17. Lupu CM, Eisenbach C, Kuefner MA, Schmidt J, Lupu AD, Stremmel W, et al. An orthotopic colon can-
cer model for studying the B7-H3 antitumor effect in vivo. Journal of gastrointestinal surgery: official
journal of the Society for Surgery of the Alimentary Tract. 2006 May; 10(5):635–645. PMID: 16713537
18. Luo L, Chapoval AI, Flies DB, Zhu G, Hirano F, Wang S, et al. B7-H3 enhances tumor immunity in vivo
by costimulating rapid clonal expansion of antigen-specific CD8+ cytolytic T cells. J Immunol. 2004 Nov
1; 173(9):5445–5450. PMID: 15494491
19. Prasad DV, Nguyen T, Li Z, Yang Y, Duong J, Wang Y, et al. Murine B7-H3 is a negative regulator of T
cells. J Immunol. 2004 Aug 15; 173(4):2500–2506. PMID: 15294965
B7-H3 in Autoimmune Diseases
PLOS ONE | DOI:10.1371/journal.pone.0130126 June 11, 2015 15 / 16
20. Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Yamazaki T, et al. B7-H3 regulates the devel-
opment of experimental allergic conjunctivitis in mice. Immunol Lett. 2007 Oct 31; 113(1):52–57. PMID:
17825429
21. Nagashima O, Harada N, Usui Y, Yamazaki T, Yagita H, Okumura K, et al. B7-H3 contributes to the de-
velopment of pathogenic Th2 cells in a murine model of asthma. J Immunol. 2008 Sep 15; 181
(6):4062–4071. PMID: 18768862
22. Xu L, Zhang G, Zhou Y, Chen Y, XuW, Wu S, et al. Stimulation of B7-H3 (CD276) directs the differenti-
ation of humanmarrow stromal cells to osteoblasts. Immunobiology. 2011 Dec; 216(12):1311–1317.
doi: 10.1016/j.imbio.2011.05.013 PMID: 21893365
23. Wang L, Fraser CC, Kikly K, Wells AD, Han R, Coyle AJ, et al. B7-H3 promotes acute and chronic allo-
graft rejection. Eur J Immunol. 2005 Feb; 35(2):428–438. PMID: 15682454
24. SuhWK, Gajewska BU, Okada H, Gronski MA, Bertram EM, Dawicki W, et al. The B7 family member
B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat Immunol. 2003
Sep; 4(9):899–906. PMID: 12925852
25. SuhWK, Wang SX, Jheon AH, Moreno L, Yoshinaga SK, Ganss B, et al. The immune regulatory pro-
tein B7-H3 promotes osteoblast differentiation and bone mineralization. Proc Natl Acad Sci U S A.
2004 Aug 31; 101(35):12969–12973. PMID: 15317945
B7-H3 in Autoimmune Diseases
PLOS ONE | DOI:10.1371/journal.pone.0130126 June 11, 2015 16 / 16
